Agree with that, soulman. I've long seen XRF as a potential target for CPB who have a track record of taking out smaller firms in their wider field of scientific testing and analysis.

I hold quite a few CPB, one of my best ASX performers of recent years. Otherwise, might have already had a nibble at XRF!